HUMA.NASDAQHumacyte, INC
Form 4: Humacyte Director Michael T. Constantino Reports Transaction in Company Stock
Sentiment:
SEC Form 4 Filing
Director Michael T. Constantino reports the acquisition and disposal of Humacyte, Inc. common stock on August 15, 2024.
Summary
- On August 15, 2024, Michael T. Constantino, a director of Humacyte, Inc., engaged in a transaction involving the company's common stock.
- Constantino acquired 3,100 shares of common stock at a price of $6.2883 per share.
- Following the reported transaction, Constantino beneficially owns 12,350 shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a transaction by a company director, indicating a neutral sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/15/2024 | Date of stock transaction (purchase and disposal) by Michael T. Constantino. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.